3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pancreatic Neoplasms
21
Lung Neoplasms
14
Carcinoma, Non-Small-Cell Lung
14
Urinary Bladder Neoplasms
12
Ovarian Neoplasms
9
Neoplasm Metastasis
7
Non-Muscle Invasive Bladder Neoplasms
6
Cholangiocarcinoma
6
Triple Negative Breast Neoplasms
5
Lymphoma, Large B-Cell, Diffuse
5
Colorectal Neoplasms
5
Fallopian Tube Neoplasms
4
Breast Neoplasms
4
Biliary Tract Neoplasms
4
Parkinson Disease 4, Autosomal Dominant Lewy Body
3
Nasopharyngeal Carcinoma
3
Melanoma
3
Carcinoma, Transitional Cell
3
Uterine Cervical Neoplasms
2
Urologic Neoplasms
2
Recurrence
2
Rectal Neoplasms
2
Osteosarcoma
2
Neoplasms
2
Lymphoma, T-Cell, Peripheral
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Follicular
2
Gallbladder Neoplasms
2
Colonic Neoplasms
2
Bile Duct Neoplasms
2
Interventions
Cytarabine
5
Whole-Body Irradiation
4
fludarabine
3
Specimen Handling
3
Peripheral Blood Stem Cell Transplantation
3
Injections
3
Cyclophosphamide
3
CPX-351
3
Blood Specimen Collection
3
venetoclax
2
nilotinib
2
luspatercept
2
ivosidenib
2
fludarabine phosphate
2
decitabine and cedazuridine drug combination
2
asciminib
2
Tacrolimus
2
Mycophenolic Acid
2
Melphalan
2
Liposomes
2
Idarubicin
2
Granulocyte Colony-Stimulating Factor
2
Gemtuzumab
2
Filgrastim
2
Daunorubicin
2
Cyclosporine
2
Busulfan
2
Biopsy
2
Azacitidine
2
tocilizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Myeloproliferative Disorders
×
Gemcitabine
×
30 days
×
Clear all
No trials found.